Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation

Details for Australian Patent Application No. 2003239030 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 0201844-8 17.06.02 SE; 60/388,747 17.06.02 US

26 February 2004 Application Open to Public Inspection

Published as AU-A-2003239030

10 April 2008 Assignment before Grant

Cartela AB The application has been assigned to Cartela R&D

13 November 2008 Alteration of Name

The name of the applicant has been altered to Cartela R & D AB

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.